Table 1 Rituximab as an element of... | American Society of Hematology

Table 1

Rituximab as an element of conditioning reduces the incidence of aGVHD

Grades	With rituximab	Without rituximab
aGVHD II-IV	3/17 (17.6%)	9/17 (52.9%)*
aGVHD I-IV	3/17 (17.6%)	14/17 (82.3%)†

P calculated by χ² test.

P = .031.

P < .001.